Occam Immune is an Academic Research Organization providing immune monitoring solutions tailored for pharma and biotech companies conducting clinical trials
Joined May 2024
- Tweets30
- Following104
- Followers125
- Likes19
Pinned Tweet
We are excited to launch OCCAM Immune, an Academic Research Organization providing streamlined #ImmuneMonitoring services to the pharma and biotech industry for clinical studies.
Check out the immune monitoring as a service options we provide here >>> occam-immune.com/
Our CMO Dr. Thomas Marron (@DrTomMarron) has been a force for OCCAM Immune at #SITC26! Here he is at Booth #1031 with our CEO Erik Wambre (@WambreErik) and CSO Seunghee Kim-Schulze, talking spatial profiling of the tumor microenvironment. #ImmunoOncology
Tomorrow at #SITC26: our CSO Seunghee Kim-Schulze presents Poster #148 in the Poster Hall. Catch her at lunch (12–1:30 pm MT) or the poster reception (6:40–8:10 pm MT).
Until then, find us and CEO @WambreErik at Booth #1031! #ImmunoOncology
33
Today at #SITC26: our CMO Dr. @DrTomMarron co-leads the New Agents in Development and Emerging Tech program and speaks at 3:40 pm MT on how AROs use biospecimens to inform drug development.
Want to keep the conversation going? Visit Booth #1031 on November 6–7
1
27
OCCAM Immune is at #SITC26 in Phoenix next week!
Visit us at Booth #1031, Nov 6–7.
Come talk with our CEO Erik Wambre (@WambreErik) and CSO Seunghee Kim-Schulze about immune monitoring for your translational research and clinical trials.
#ImmunoOncology
OCCAM Immune retweeted
16-channel imaging of Ovarian Serous Cystadenocarcinoma, acquired on the Orion Spatial Biology platform. 🌟
Image is courtesy of Zhihong Chen and custody of Human Immune Monitoring Center, @Occamimmune, @IcahnMountSinai.
#SpatialBiology #SpatialProteomics #OvarianCancer
Happy Holidays from the OCCAM Immune Team! 🎄
Thank you to all our partners and supporters for an amazing year. We’re excited for what’s ahead in 2025 and look forward to continuing this journey together.
Wishing you a joyful holiday season!
#HappyHolidays #Immunology
OCCAM Immune retweeted
Excited to see that I rank among the highest cited people in the field of immunology and medicine. Proud of our work! #researcher #research #immunology #medicine #mountsinai #dermatology #skin #disease #translational #eczema #allergy #alopecia #treatment #inflammation #aging
Excited to announce that our CEO Erik Wambre, will be presenting "Immunophenotypes of Food Allergy & Responses to Immunotherapy Across the Life Course" Friday Nov 22 at the @EAACI_HQ FAAM-EUROBAT conference in Athens, Greece!
Reach out if you'd like to meet—we’d love to connect!
1
89
DM if you'd like to meet the @OCCAMimmune team at the 'Next Generation Immunotherapy Discoveries' symposium Oct 3.
We'd love to introduce our custom immune profiling capabilities to investigators & industry representatives planning clinical trials of cutting-edge immunotherapy.
Join us ONLINE Oct 3 for a joint symposium hosted by @InnatePharma & @IcahnMountSinai to find out what upcoming immunotherapy strategies are envisioned by @MiriamMerad @EricVivier @EJohnWherry & more.
Don’t miss out—register now for FREE: innate-symposium.com/
👇 Program 👇
164
JOIN US in-person at the 'Next Generation Immunotherapy Discoveries' Symposium, Oct 3rd in NYC, a great opportunity to meet CEO @ErikWambre & discuss cutting edge immune monitoring for clinical studies of new immunotherapies at the lunch or cocktail reception:
Discover how the @Occamimmune mass cytometry panel helped Samir Parekh and @ovanoekelen uncover how Iberdomide activates immune cells to fight cancer in the bone marrow of patients with relapsed/refractory #MultipleMyeloma. Study in @CellRepMed 👇
loom.ly/UM5gtxk
Iberdomide is a CELMoD: a new class of immunomodulatory drugs for treating myeloma. We employed standardized mass cytometry to show that Iberdomide enhances effector T and NK cells, offering new mechanistic insights into how Iberdomide boosts innate and adaptive tumor immunity.
1
1
115
Explore our full range of cutting-edge technologies for immunophenotyping patient responses to new immunotherapies to reveal how they work here >>> occam-immune.com.
2
80
Check out our paper in @AllergyEaaci! Our antigen-specific T cell assays track the key changes in peanut-specific T cells during treatment, revealing the precise immune responses that underpin the immunotherapy's success in combatting #PeanutAllergy. loom.ly/FTcfMJ8
1
1
64
By unveiling an immunotherapy's mechanism of action, our antigen-specific T cell assays pave the way for targeted & effective treatments.
More info on the cutting-edge immune monitoring services we provide to support immunotherapy clinical trials here >>> occam-immune.com/
42
Meet @DrTomMarron, a pioneer of mechanistic clinical trials of cancer immunotherapy. Read about how Tom & @MiriamMerad's TARGET and INTERACT programs integrate immune profiling to provide actionable insights into how to treat cancer and other diseases >>> loom.ly/QxEyzfE
